Related by context. All words. (Click for frequent words.) 72 endometrial cancers 68 endometrial hyperplasia 67 ovarian cancers 67 nonmelanoma skin cancers 67 ductal cancer 66 adenomatous polyps 66 lobular cancer 66 rectal cancers 66 atypical hyperplasia 66 invasive breast cancer 66 testicular cancers 65 colon cancers 65 colorectal cancers 65 advanced adenoma 65 salpingo oophorectomy 64 endometrial carcinoma 64 breast endometrial 64 lobular breast cancer 64 esophageal cancers 63 bladder cancers 63 adenocarcinomas 63 peritoneal cancer 63 breast cancer recurrence 63 renal cell carcinomas 63 BRCA2 mutations 62 advanced adenomas 62 colorectal adenomas 62 adenoma 62 colorectal cancer CRC 62 ductal breast cancer 62 venous blood clots 62 colon polyps 62 nonmelanoma skin cancer 62 breast carcinoma 62 prostate cancers 62 lobular carcinoma 62 BRCA1 mutation carriers 62 endometrial cancer 62 squamous cell carcinomas 62 bowel cancers 62 Uterine cancer 62 adenomas 62 squamous cell cancers 62 atypical ductal hyperplasia 62 colon breast 61 breast uterine 61 gastrointestinal cancers 61 breast cancers 61 invasive carcinoma 61 estrogen progestin therapy 61 BRCA mutations 61 breast ovarian 61 thyroid cancers 61 colorectal adenoma 61 oophorectomy 61 GISTs 61 axillary lymph nodes 61 vaginal cancers 61 colorectal neoplasms 61 anal cancers 61 precursor lesions 61 recurrent VTE 61 cancers 61 uveal melanoma 61 basal cell skin 60 atypia 60 cervical breast 60 oropharyngeal cancer 60 colorectal tumors 60 osteosarcomas 60 pancreatic lung 60 estrogen progestin combination 60 pre cancerous polyps 60 mesotheliomas 60 bilateral oophorectomy 60 nonsmall cell lung cancer 60 basal cell carcinomas 60 HER2 positive cancers 60 pre cancerous lesions 60 pancreatic prostate 60 breast cancer recurrences 60 colorectal polyp 60 premenopausal breast cancer 60 benign growths 60 colon tumors 60 BRCA1 mutations 60 ductal carcinomas 60 carcinomas 60 leiomyomas 60 polycystic ovary syndrome PCOS 60 colorectal cancer 60 skin cancers 60 uterine tumors 60 ovulatory cycles 60 prostate colon 60 fibrocystic disease 60 precancerous cervical 60 distal colon cancer 60 NOLVADEX 60 rectal cancer 59 ovarian lung 59 colorectal polyps 59 GnRH agonists 59 invasive cervical cancer 59 intestinal polyps 59 vulvar cancer 59 abnormal Pap smears 59 thromboembolisms 59 ovarian breast 59 contralateral breast 59 colorectal neoplasia 59 precancerous lesions 59 axillary dissection 59 precancerous polyp 59 endometriosis ovarian cysts 59 BRCA2 mutation carriers 59 breast carcinomas 59 Uterine fibroids 59 pulmonary metastases 59 lung cancers 59 ductal lobular 59 metastatic prostate 59 liver metastasis 59 advanced neoplasia 59 basal cell carcinoma BCC 59 cisplatin chemotherapy 59 vulvar cancers 59 hormone receptor negative 59 malignancies 59 squamous cell 59 CMV infection 59 benign noncancerous 59 Squamous 59 gastric cancer 59 invasive ductal 59 hamartomas 59 ovarian cervical 58 EUS FNA 58 situ LCIS 58 pancreatic cancers 58 postmenopausal hormone 58 frequently benign tumor 58 Adjuvant chemotherapy 58 mammary cancers 58 laparoscopically assisted 58 micrometastases 58 hormone therapy estrogen 58 distant metastasis 58 prophylactic mastectomies 58 intravenous bisphosphonates 58 cervical carcinoma 58 gynecologic malignancy 58 prostate pancreatic 58 basal cell nevus syndrome 58 prostate cancer CaP 58 distant metastases 58 squamous cell lung cancer 58 thrombotic events 58 seminoma 58 Endometrial cancer 58 abnormal growths 58 breast colon 58 epithelial ovarian 58 HNSCC 58 Colon polyps 58 bowel polyps 58 preoperative chemotherapy 58 BRCA2 gene mutation 58 gynecological cancers 58 genital herpes infections 58 colorectal pancreatic 58 basal cell cancers 58 anal lesions 58 gene BRCA2 58 inherited mutations 58 adjuvant radiotherapy 58 gynecologic cancers 58 malignant polyps 58 Thyroid nodules 58 HER2 positive tumors 58 pharyngeal cancer 58 precancerous tumors 58 colonic polyps 58 atypical fractures 58 brain metastases 57 pre cancerous growths 57 metachronous 57 colon rectal 57 hemorrhagic complications 57 epithelial ovarian cancer 57 ovarian cancer 57 de ath 57 CIN3 57 ischemic strokes 57 situ DCIS 57 cutaneous melanoma 57 recurrent UTI 57 pCR 57 abnormal Pap test 57 sentinel lymph node biopsy 57 prostate breast 57 gastric cancers 57 lung colorectal 57 adenomatous 57 estrogen receptor negative 57 skeletal metastases 57 premalignant 57 hereditary breast cancer 57 bone metastasis 57 endometrial 57 sentinel node biopsy 57 squamous cell carcinoma SCC 57 thrombotic complications 57 familial pancreatic cancer 57 bladder prostate 57 fibroadenomas 57 thromboembolic events 57 atherosclerotic lesions 57 grade gliomas 57 medullary thyroid cancer 57 chlamydial infection 57 carcinoid 57 GIST tumors 57 contralateral breast cancer 57 venous thrombosis 57 ovarian pancreatic 57 serous ovarian cancer 57 solar keratosis 57 VTEs 57 urothelial cancer 57 perioperative morbidity 57 axillary node dissection 57 ovarian hormones 57 precancers 57 EGFR mutation 57 hemorrhagic strokes 57 colorectal breast 57 mammographic density 57 recurrent venous thromboembolism 57 CMV disease 57 operable breast cancer 57 premature menopause 57 histological subtype 57 thyroid nodules 57 intestinal metaplasia 57 invasive ductal breast cancer 57 ovarian tumors 57 lung lesions 57 gastrectomy 57 mammary tumors 57 repigmentation 57 cervical lesions 57 breast tumors 57 breast pancreatic 57 cancerous polyps 57 undergoing hysterectomy 57 prostate TURP 57 BRCA mutation carriers 57 BRCA gene mutations 57 neoplasias 57 leukaemias 57 locoregional recurrence 57 catheter angiography 57 HER2 overexpression 57 malignant neoplasms 57 venous thromboembolic events 57 invasive ductal carcinoma 57 allogeneic HSCT 57 pleural mesothelioma 56 precancerous spots 56 precancerous colon polyps 56 nonproliferative 56 benign breast 56 epithelial tumors 56 pancreatic adenocarcinoma 56 cervical lymph node 56 spontaneously regress 56 ovulations 56 candidemia 56 sentinel nodes 56 breast cervical 56 testicular tumors 56 polyp recurrence 56 hamartoma 56 neural tube birth defects 56 postmenopausal breast cancer 56 chromosomal abnormalities 56 Heavy menstrual bleeding 56 lymph node metastases 56 nonvertebral fractures 56 hormone receptor positive 56 fibroids endometriosis 56 breast tenderness 56 BRCA2 carriers 56 squamous cell skin 56 testicular germ cell 56 colon rectal cancer 56 node metastases 56 ovarian uterine 56 cervical vaginal 56 oral contraceptive pills 56 HbF 56 undergone hysterectomy 56 underwent prostatectomy 56 tamoxifen 56 curative resection 56 transfusion syndrome 56 vaginal lesions 56 lymph node removal 56 dexrazoxane 56 penile cancers 56 metastatic lung cancer 56 breast biopsies 56 hepatectomy 56 metastases 56 axillary lymph node dissection 56 abnormal Pap 56 ALND 56 invasive lobular 56 prostate lung 56 endometrial tumors 56 premenopausal 56 medulloblastomas 56 ovulation induction 56 carcinoid tumor 56 Basal cell 56 Postoperative complications 56 KRAS mutations occur 56 preventive mastectomies 56 precancerous condition 56 rebleeding 56 malignant lesions 56 bacterial vaginosis 56 precancerous lesion 56 thromboembolic disease 56 dentinal hypersensitivity 56 hepatocellular cancer 56 spine fractures 56 cancerous lesions 56 prostate carcinoma 56 BRCA2 mutation 56 prophylactic mastectomy 56 abnormal mammograms 56 lobular carcinomas 56 uterine cancer 56 corticosteroid therapy 56 tumor recurrence 56 congenital abnormalities 56 recurrent UTIs 56 Fibroid tumors 56 precancerous polyps 56 recurrent metastatic 56 H. pylori eradication 56 polyp detection 56 preoperative radiotherapy 56 lung metastases 56 neoplasms 56 hydroxychloroquine 56 ruptured aneurysms 56 cancerdefine 56 Tumor shrinkage 56 cranial radiation 56 invasive carcinomas 56 colorectal lung 56 neural tube defect 56 BRCA1 mutation 56 ovarian carcinoma 56 androgen ablation 56 intraoperative complications 56 colon rectum 56 oral clefts 56 colorectal gastric 56 prostate cancer metastases 56 deep venous thrombosis 56 PSADT 56 ASCUS 56 carotid stenosis 56 glioma rarer 56 liver metastases 56 prostate ovarian 56 lobular 56 fetal malformations 56 faulty BRCA genes 55 germline mutations 55 lung adenocarcinomas 55 radical nephrectomy 55 HER2 amplification 55 radioiodine therapy 55 K ras mutations 55 hereditary predisposition 55 fewer uterine cancers 55 PCNSL 55 microbleeds 55 metastatic HER2 positive 55 curable cancers 55 distal colon 55 sarcomas 55 cervical dysplasia 55 endogenous estrogen 55 prostate abnormalities 55 cranial irradiation 55 metastatic neuroendocrine tumors 55 androgen suppression 55 Malignant tumors 55 abnormal Pap smear 55 neuroblastomas 55 herpes infection 55 progesterone receptor negative 55 Human papilloma virus 55 endometrial kidney 55 glioma tumors 55 Erythropoietic therapies may 55 GBM tumors 55 premalignant lesions 55 uterine ovarian 55 benign lesions 55 spontaneous preterm birth 55 LHRH agonists 55 untreated celiac disease 55 flutamide 55 precocious puberty 55 nonvertebral fracture 55 B7 H3 55 Polyps 55 genes BRCA1 55 letrozole Femara 55 axillary nodes 55 pre menopausal 55 benign polyps 55 elevated triglyceride levels 55 colorectum 55 leiomyosarcoma 55 beta carotene supplementation 55 malignant melanomas 55 esophageal tumors 55 basal cell 55 BRCA deficient 55 intraductal 55 ADPKD 55 dysglycemia 55 oesophageal adenocarcinoma 55 DCIS lesions 55 CC genotype 55 colorectal tumor 55 malignancy 55 proximal colon 55 fallopian tube cancers 55 chromosomal aberrations 55 bladder ovarian 55 urinary bladder cancer 55 prednisone prednisolone 55 preterm deliveries 55 tamoxifen therapy 55 osteoporotic fractures 55 colorectal carcinoma 55 atrophic gastritis 55 recurrent NSCLC 55 LHRH receptor positive 55 aromatase inhibitor therapy 55 prostate adenocarcinoma 55 nonischemic 55 relapsed MM 55 PCa 55 lung tumors 55 hormonally sensitive 55 meningiomas 55 BRCA gene mutation 55 prolonged QT interval 55 ocular toxicity 55 atrial arrhythmias 55 infantile hemangiomas 55 peritoneal carcinomatosis 55 recurrent miscarriages 55 upper gastrointestinal bleeding 55 perimenopausal women 55 mutated BRCA1 55 primary ovarian insufficiency 55 autoantibody positive 55 Candida infection 55 unresectable tumors 55 androgen deprivation 55 BRCA mutation 55 overexpress HER2 55 chronic prostatitis 55 HBeAg negative 55 BRCA2 gene 55 aneuploidies 55 Recurrences 55 AVODART 55 Colorectal cancers 55 HCV infections 55 cutaneous squamous cell carcinoma 55 Li Fraumeni 55 Brain metastases 55 nonmetastatic 55 squamous cell cancer 55 ovulatory infertility 55 carcinoid tumors 55 BRCA carriers 55 H. pylori infection 55 urolithiasis 55 seminomas 55 colorectal carcinomas 55 telomere lengths 55 familial ALS 55 postoperative AF 55 metastatic lesions 55 nasopharyngeal cancer 55 fibrocystic changes 55 conjugated estrogen 55 lobular involution 55 Ductal carcinoma 55 FGFR2 gene 55 axillary node 55 postoperative atrial fibrillation 54 leukemias lymphomas 54 lung pancreatic 54 egg follicles 54 gynecologic cancer 54 ductal 54 neuroendocrine carcinoma 54 mycophenolate mofetil 54 polyps 54 gynecological cancer 54 p# mutations 54 micrometastasis 54 varicella infection 54 abnormal uterine bleeding 54 Thyroid cancer 54 cervix uteri 54 esophageal gastric 54 fibrocystic 54 glandular tissue 54 lymph node biopsies 54 cisplatin resistant 54 LNG IUS 54 Digital Mammographic Imaging 54 Mitomycin C 54 hepatocellular carcinoma 54 pelvic malignancies 54 GI bleeds 54 HGPIN 54 lung prostate 54 PARP inhibition 54 ALCL 54 lymphatic tissue 54 gastric adenocarcinoma 54 thromboembolism 54 Pap smear screening 54 bile duct cancers 54 precancerous cervical lesions 54 melanoma 54 intra abdominal abscess 54 bacteriuria 54 ovarian hyperstimulation syndrome 54 ano genital warts 54 cerebral infarction 54 ovarian malignancy 54 pyloric stenosis 54 parathyroid 54 Zinc deficiency 54 colorectal cancer incidence 54 colon adenomas 54 DMPA 54 pituitary tumors 54 trans retinoic acid 54 cirrhosis liver failure 54 pancreatic ovarian 54 dysplastic lesions caused 54 abnormal genital 54 Epstein Barr virus EBV 54 lung adenocarcinoma 54 EBRT 54 arterial calcification 54 radiofrequency ablation RFA 54 S. aureus infection 54 melanoma tumors 54 lymphomas 54 HER2 positive breast cancer 54 breast cancer genes BRCA1 54 molar pregnancy 54 colon esophageal 54 external genital lesions 54 orchiectomy 54 Squamous cell 54 tibolone 54 carcinoma 54 microdeletions 54 malignant neoplasm 54 metastatic colorectal 54 SUVmax 54 leiomyoma 54 medulloblastoma tumors 54 ovarian endometrial 54 nasopharyngeal carcinoma 54 SHBG levels 54 breast asymmetry 54 Hurthle cell 54 excisional biopsy 54 lymph node dissection 54 TRUS biopsy 54 lymphadenectomy 54 pheochromocytomas 54 nodal metastases 54 pulmonary metastasis 54 histologic subtype 54 deep venous thromboses 54 chemoembolization 54 irregular menstrual cycles 54 Fatty Liver Disease 54 carcinoma HCC 54 malignant growths 54 HPV subtypes 54 cardio vascular disease 54 hormone therapy 54 chronic rhinosinusitis 54 adrenal function 54 pre cancerous lesion 54 noncancerous tumors 54 pancreatic endocrine 54 ticlopidine 54 squamous cell carcinoma 54 endocrine therapies 54 recurrent stroke 54 Pancreatic neuroendocrine tumors 54 uterine cervix 54 anovulatory infertility 54 cell carcinomas 54 CaP 54 abnormal mammogram 54 malignant lymphoma 54 chorioamnionitis 54 benign proliferative breast 54 EXJADE 54 amenorrhoea 54 preventive mastectomy 54 FGFR2 54 desogestrel 54 antiplatelet drugs 54 CIN2 + 54 Malignant Melanoma 54 KRAS mutations 54 metastatic disease 54 chronic periodontitis 54 colorectal 54 invasive ductal carcinomas 54 Endometrial 54 Radical prostatectomy 54 malignant tumors 54 NMP# 54 HPV infections 54 ductal adenocarcinoma 54 ovarian hyperstimulation syndrome OHSS 54 endometrial ablation 54 adenomatous polyp 54 EGFRIs 54 cerebral microbleeds 54 cancerous lumps 54 precancer 54 metastatic tumors 54 Glioblastoma Multiforme GBM 54 BRAF mutations 54 Thalomid ® 54 removed laparoscopically 54 thoracoscopic lobectomy 54 hysterectomies performed 54 CYT# potent vascular disrupting 54 neoadjuvant therapy 54 transaminase levels 54 recurrent ovarian 54 gallstone disease 54 myelomas 54 pelvic lymphadenectomy 54 progestin therapy 54 parous women 54 TGFBR1 * 6A 54 cardiac dysfunction 54 Cholangiocarcinoma 54 undergone hysterectomies 54 radiosensitivity 54 systemic scleroderma 54 ductal lavage 54 Prostate Lung Colorectal 54 GBMs 54 hyperintense lesions 54 metastatic gastric 54 Human papillomavirus HPV 54 genistein 54 carotid artery blockage 54 Folate deficiency 54 cervical lymph nodes 54 undergone radical prostatectomy 54 T1DM 54 HoLEP 54 ovarian 54 plus progestin 54 papillomas 54 anal penile 54 NAFLD 54 thyroid hormone levels 54 renal tumors 54 singleton pregnancy 54 metastatic melanomas 54 RAS mutations 54 pelvic lymph nodes 54 Hepatocellular Carcinoma HCC 54 paclitaxel eluting stents 54 Squamous cell carcinomas 54 exemestane 54 hypermethylated 54 postoperative morbidity 53 multiple gestations 53 MGd 53 Papillary 53 surgical biopsies 53 recurrent miscarriage 53 thermogram 53 adjuvant therapy 53 lung metastasis 53 neoplasia 53 grade cervical intraepithelial 53 cervical cancers 53 Torsades de Pointes 53 CHDs 53 adjuvant therapies 53 symptomatic fibroids 53 diverticular bleeding 53 esophageal adenocarcinoma 53 cervical intraepithelial neoplasia 53 colonoscopy screenings 53 fibrocystic breast disease 53 myelomeningocele 53 TEAEs 53 advanced HER2 positive 53 Menopausal hormone therapy 53 acoustic neuromas 53 gastric cardia 53 pre cancerous 53 papilloma 53 adjuvant radiation 53 papillary carcinoma 53 adrenocortical cancer 53 tumors 53 hepatocellular carcinoma HCC 53 bladder tumors 53 BRAF gene 53 debulking surgery 53 TT genotype 53 mammary duct 53 ovary uterus 53 cytoreductive surgery 53 revascularization procedures 53 nodal metastasis 53 Hashimoto thyroiditis 53 acute leukemias 53 epithelial cancers 53 genitourinary tract 53 Barrett esophagus BE 53 genital ulcers 53 sarcomatoid 53 urine cytology 53 estrogen therapy 53 non aspirin NSAIDs 53 fallopian tube carcinoma 53 supratentorial 53 HER2 amplified 53 hepatocellular carcinomas 53 sentinel node 53 Hormonal therapy 53 mediastinoscopy 53 metastatic bladder 53 heavy menstrual bleeding 53 vulvar vaginal 53 coronary blockages 53 neurologic complications 53 breast cancer 53 colon cancer 53 pancreatic colon 53 tamoxifen Nolvadex ® 53 pheochromocytoma 53 benign nodules 53 dysplastic lesions 53 mutated K ras 53 leukemia ALL 53 multimodality therapy 53 MGUS 53 follicular thyroid cancer 53 neuroendocrine cancers 53 castrate resistant 53 microvascular disease 53 AAT deficiency 53 β blockers 53 thromboses 53 vaginal hysterectomy 53 post thrombotic syndrome 53 total thyroidectomy 53 thoracic aortic aneurysm 53 ovarian stimulation 53 postoperative complications 53 mucinous 53 digestive tract cancers 53 oral squamous cell 53 noncancerous growths 53 cervical neoplasia 53 melanoma lesions 53 choriocarcinoma 53 ependymomas 53 thyrotropin levels 53 esophageal squamous cell carcinoma 53 tumoral 53 post menopausal 53 cancerous breast 53 pancreatic bladder 53 papillary thyroid cancer 53 Gliomas 53 cervical precancers 53 progestins 53 chlamydial infections 53 male hormone androgen 53 polycystic ovarian syndrome PCOS 53 carotid plaque 53 fibroma 53 varicoceles 53 pneumonectomy 53 HPV# 53 colon prostate 53 postoperative chemotherapy 53 differentiated thyroid 53 congenital anomalies 53 Chlamydia trachomatis infection 53 nonalcoholic steatohepatitis NASH 53 underarm lymph nodes 53 infiltrating ductal carcinoma 53 folate supplementation 53 lichen planus 53 Adenomas 53 antiandrogens 53 noncardiac 53 ischemic colitis 53 haemorrhagic stroke 53 undergo mastectomy 53 promoter hypermethylation 53 liver scarring 53 dysplastic nevi 53 cholangiocarcinoma 53 basal cell carcinoma 53 myoma 53 nuchal translucency 53 cytological 53 oropharyngeal cancers 53 papillary renal cell carcinoma 53 neoplastic lesions 53 congenital malformations 53 postoperative mortality 53 BRCA2 gene mutations 53 ovaries removed 53 computed tomography CT scans 53 impair fertility 53 estrogen receptor positive 53 hypertrophic scars 53 hepatic metastases 53 breast cancer susceptibility genes 53 Rectal cancer 53 tumor subtypes 53 neuroendocrine tumors 53 extracolonic findings 53 mtDNA mutations 53 fetal chromosomal 53 liver resection 53 Colorectal cancer CRC 53 Li Fraumeni syndrome 53 esophagus colon 53 pre malignant lesions 53 situ CIS 53 reinfarction 53 preterm delivery 53 prostate carcinomas 53 reflux disease 53 colon polyp 53 BRCA1 BRCA2 53 nonalcoholic steatohepatitis 53 cytoreduction 53 obese postmenopausal 53 HIV HCV coinfected 53 subclinical hyperthyroidism 53 LQTS 53 HPV infection 53 BRCA genes 53 tumor histology 53 gastric carcinoma 53 TNF blockers 53 venous thromboembolism 53 ABCB1 53 overt hepatic encephalopathy HE 53 SLNB 53 genital HPV infections 53 carcinoids 53 anticonvulsant medications 53 Kaplan Meier analysis 53 metastatic adenocarcinoma 53 NNRTI resistance 53 gastrointestinal malignancies 53 bronchogenic carcinoma 53 undergoing radical prostatectomy 53 thyroid carcinoma 53 Hemangiomas 53 Carotid stenting 53 CT coronary angiography 53 chronically immunosuppressed solid 53 Oral contraceptive 53 amyloid deposition 53 vaginal hysterectomies 52 hormonal therapy 52 perioperative mortality 52 aromatase 52 KIF6 carriers 52 lobules 52 MALT lymphoma 52 lung carcinomas 52 esophagogastroduodenoscopy 52 breast lesions 52 Aortic aneurysms 52 ovarian cysts 52 hormonal treatments 52 Gastric cancer 52 squamous histology 52 fluoroquinolone resistance 52 hypopituitarism 52 lymphomas leukemias 52 asymptomatic carotid stenosis 52 gonococcal infections 52 Leukemias 52 bicuspid aortic valves 52 premalignant lesion 52 radiation therapy SBRT 52 microwave hyperthermia 52 PNET 52 malignant brain 52 Legg Calvé Perthes disease 52 fluvastatin 52 Ischemic strokes 52 genital lesions 52 progestagen 52 steroid dexamethasone 52 skin sparing mastectomy 52 parathyroid carcinoma 52 Surgical excision 52 thrombophilia 52 densest breasts 52 mTOR inhibitors 52 ovarian colon 52 prostate cancer PCa 52 haematopoietic 52 keloids 52 GSTP1 52 ocular melanoma 52 gene amplification 52 urothelial carcinoma 52 irregular ovulation 52 chemotherapy cisplatin 52 melanomas 52 postoperative delirium 52 androgen suppression therapy 52 oesophageal 52 breast cancer gene mutation 52 locoregional 52 radical retropubic prostatectomy 52 CIN2 52 atherothrombotic events 52 deCODE BreastCancer 52 selenium supplementation 52 HPVs 52 vasomotor symptoms 52 naturally occurring estrogen 52 folic acid intake 52 oligodendrogliomas 52 HER2 positive breast 52 precancerous growths 52 spontaneous preterm delivery 52 Basal Cell 52 antiandrogen 52 neoadjuvant radiation 52 Celecoxib APC trial 52 vertebral fracture 52 exemestane Aromasin 52 schwannomas 52 abdomen pelvis 52 octreotide LAR 52 LRP5 52 hypervascular 52 severe periodontitis 52 cervical abnormalities 52 varices 52 abnormal pap smears 52 cervical uterine 52 mammographic screening 52 subependymal giant cell 52 Mylotarg 52 HPV genotypes